Matrix-based pulse release pharmaceutical formulation
AssigneeMallinckrodt Inc.
InventorsAshwini Gadre, Mark R. Benmuvhar, Brian Kai-Ming Cheng, Vishal Gupta, Cliff J. Herman
Life of this patent
Estimating the term…
Loading patent…
AssigneeMallinckrodt Inc.
InventorsAshwini Gadre, Mark R. Benmuvhar, Brian Kai-Ming Cheng, Vishal Gupta, Cliff J. Herman
Estimating the term…
The present invention relates to an oral pulse release pharmaceutical composition, which comprises a polymer matrix core, wherein at least one pharmaceutically active ingredient is distributed within the core and on the outer surface of the core. Amphetamine salts, among a number of other pharmaceutically active ingredients, can be formulated as a pharmaceutical composition described herein. The present invention also provides a method for preparing an immediate release component on a solid pharmaceutical formulation.
An oral pharmaceutical composition comprising a polymer matrix, a first pharmaceutically active ingredient distributed substantially uniformly within the polymer matrix and a second pharmaceutically active ingredient deposited on the surface of the polymer matrix.
A method of preparing an immediate release component of a solid pharmaceutical composition, wherein the method comprises the steps of:
An oral pharmaceutical composition comprising an enteric polymer matrix, wherein a pharmaceutically active ingredient is substantially uniformly distributed throughout the enteric polymer matrix.
Dependencies are inferred from the claim text.